Voyager Therapeutics (VYGR) Long-Term Investments (2015 - 2026)
Voyager Therapeutics (VYGR) posted Long-Term Investments of $30.2 million for Q1 2026, up 475.53% sequentially from $5.2 million in Q4 2025, and down 48.93% YoY from $59.1 million in Q1 2025.
Voyager Therapeutics (VYGR) Long-Term Investments (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported Long-Term Investments for 9 years, with the latest figure at $30.2 million in Q1 2026.
- Quarterly Long-Term Investments fell 48.93% year-over-year to $30.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.2 million (down 48.93% YoY) and the FY2025 annual result came in at $5.2 million, down 92.02% from the prior year.
- Long-Term Investments improved to $30.2 million in Q1 2026 per VYGR's latest filing, from $5.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $65.7 million in Q4 2024 and troughed at $980000.0 in Q1 2024.
- A 3-year average of $32.5 million and a median of $30.2 million in 2026 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 5930.92% in 2025, down 92.02% in 2025.
- Over 3 years, Long-Term Investments stood at $65.7 million in 2024, then slumped by 92.02% to $5.2 million in 2025, then jumped by 475.53% to $30.2 million in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $30.2 million, $5.2 million, and $20.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | 32.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.48 Mn |
| Mar 31, 2026 | 30.18 Mn |
| Dec 31, 2025 | 5.24 Mn |
| Sep 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 46.45 Mn |
| Mar 31, 2025 | 59.10 Mn |
| Dec 31, 2024 | 65.70 Mn |
| Mar 31, 2024 | 980,000.00 |
| Sep 30, 2020 | 2.18 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Mar 31, 2020 | 1.43 Mn |
| Dec 31, 2019 | 1.92 Mn |
| Sep 30, 2019 | 2.02 Mn |
| Jun 30, 2019 | 1.28 Mn |
| Mar 31, 2019 | 1.28 Mn |
| Dec 31, 2018 | 628,000.00 |
| Sep 30, 2018 | 800,000.00 |
| Jun 30, 2018 | 860,000.00 |
| Mar 31, 2018 | 1.32 Mn |
| Dec 31, 2017 | 1.10 Mn |